acetaminophen, caffeine, dihydrocodeine bitartrate

CHEBI:CHEBI_750767

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
DIHYDROCODEINE BITARTRATE
rxcui
1596108
product_type
HUMAN PRESCRIPTION DRUG
route
ORAL
marketing_category
ANDA
labeler_name
Proficient Rx LP
manufacturer_name
Proficient Rx LP
listing_expiration_date
20241231
dea_schedule
CIII
pharm_class
Xanthines [CS]
dosage_form
CAPSULE
unii
8LXS95BSA9
nui
M0023046
pharm_class_epc
Methylxanthine [EPC]
pharm_class_pe
Central Nervous System Stimulation [PE]
pharm_class_cs
Xanthines [CS]
active_ingredient_strength
320.5 mg/1
package_marketing_start_date
20160601
marketing_start_date
20141201
generic_name
acetaminophen, caffeine, dihydrocodeine bitartrate
brand_name
Trezix
brand_name_base
Trezix
product_ndc
63187-705
application_number
ANDA204785
spl_id
cf14c5ce-0aa3-4511-9db0-7d5aa995f04d
package_ndc
63187-705-90
package_description
90 CAPSULE in 1 BOTTLE (63187-705-90)
spl_set_id
45c3c2a1-6a89-471e-b6d4-5a4cd73b987a
upc
0363187705602
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class